1. Adam T (1989) Radioiodination for therapy. Ann Clin Biochem 26: 244–245
2. Bagshawe KD, Sharma SK (1996) Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT. Transplant Proc 28: 3156–3158
3. Bagshawe K, Sharma S, Springer C, Antoniw P (1995) Antibody directed enzyme prodrug therapy: a pilot scale clinical trial. Tumour Targeting 1: 17–30
4. Bagshawe KD, Springer CJ, Searle F, Antoniw P, Sharma SK, Melton RG, Sherwood RF (1988) A cytotoxic agent can be generated selectively at cancer sites. Br J Cancer 58: 700–703
5. Blakey DC, Burke PJ, Davies DH, Dowell RI, East SJ, Eckersley KP, Fitton JE, McDaid J, Melton RG, Niculescu-Duvaz IA, Pinder PE, Sharma SK, Wright AF, Springer CJ (1996) ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumour regressions in colorectal tumor xenografts. Cancer Res 56: 3287–3292